Oramed Pharmaceuticals
ORMP
ORMP
23 hedge funds and large institutions have $1.34M invested in Oramed Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
88% less call options, than puts
Call options by funds: $4K | Put options by funds: $34K
Holders
23
Holding in Top 10
–
Calls
$4K
Puts
$34K
Top Buyers
| 1 | +$195K | |
| 2 | +$125K | |
| 3 | +$4.84K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1K |
Top Sellers
| 1 | -$90K | |
| 2 | -$25K | |
| 3 | -$9.3K | |
| 4 |
Morgan Stanley
New York
|
-$3.08K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$553 |